1. Home
  2. NLSP vs BRN Comparison

NLSP vs BRN Comparison

Compare NLSP & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • BRN
  • Stock Information
  • Founded
  • NLSP 2015
  • BRN 1956
  • Country
  • NLSP Switzerland
  • BRN United States
  • Employees
  • NLSP N/A
  • BRN N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • BRN Oil & Gas Production
  • Sector
  • NLSP Health Care
  • BRN Energy
  • Exchange
  • NLSP Nasdaq
  • BRN Nasdaq
  • Market Cap
  • NLSP 12.4M
  • BRN 11.4M
  • IPO Year
  • NLSP 2021
  • BRN N/A
  • Fundamental
  • Price
  • NLSP $1.95
  • BRN $1.15
  • Analyst Decision
  • NLSP
  • BRN
  • Analyst Count
  • NLSP 0
  • BRN 0
  • Target Price
  • NLSP N/A
  • BRN N/A
  • AVG Volume (30 Days)
  • NLSP 171.1K
  • BRN 36.9K
  • Earning Date
  • NLSP 08-12-2025
  • BRN 08-12-2025
  • Dividend Yield
  • NLSP N/A
  • BRN N/A
  • EPS Growth
  • NLSP N/A
  • BRN N/A
  • EPS
  • NLSP N/A
  • BRN N/A
  • Revenue
  • NLSP N/A
  • BRN $19,387,000.00
  • Revenue This Year
  • NLSP N/A
  • BRN N/A
  • Revenue Next Year
  • NLSP N/A
  • BRN N/A
  • P/E Ratio
  • NLSP N/A
  • BRN N/A
  • Revenue Growth
  • NLSP N/A
  • BRN N/A
  • 52 Week Low
  • NLSP $1.30
  • BRN $1.08
  • 52 Week High
  • NLSP $8.35
  • BRN $2.53
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 37.66
  • BRN 44.44
  • Support Level
  • NLSP $1.71
  • BRN $1.10
  • Resistance Level
  • NLSP $2.00
  • BRN $1.19
  • Average True Range (ATR)
  • NLSP 0.15
  • BRN 0.06
  • MACD
  • NLSP -0.03
  • BRN 0.00
  • Stochastic Oscillator
  • NLSP 21.67
  • BRN 15.79

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About BRN Barnwell Industries Inc.

Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.

Share on Social Networks: